Cigna's strong growth potential, Evernorth expansion, and stock buybacks make it undervalued. Click here to find out why CI stock is a Buy.

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the health insurance providers stocks, including ...

Aristotle Atlantic Core Equity Strategy highlighted stocks like The Cigna Group (NYSE:CI) in its Q4 2024 investor letter and explained its insights for the company. The Cigna Group (NYSE ...

Progyny Inc (PGNY) reports strong financial performance with record ART cycles and strategic expansions, despite challenges ...

US managed care insurers' Q4 2024 earnings season was characterized by generally higher medical costs amid ongoing changes to ...

Aristotle Atlantic Core Equity Strategy highlighted stocks like The Cigna Group (NYSE:CI) in its Q4 2024 investor letter and explained its insights for the company. The Cigna Group (NYSE:CI) is a ...

Health insurance company Cigna (NYSE:CI) announced in Q4 CY2024, with sales up 28.4% year on year to $65.65 billion. The company expects the full year’s revenue to be around $252 billion ...

Cigna Healthcare is the insurance segment, generating 40% of earnings. Evernorth experienced 14% YoY earnings growth in Q4 to $2.15 billion, while Cigna Healthcare EPS fell 47% to $511 million.

TD Cowen analyst Charles Rhyee lowered the firm’s price target on Cigna (CI) to $380 from $391 and keeps a Buy rating on the shares. The firm updated its estimates following Q4 results as they ...

Humana reported a Q4 EPS loss of $2.16 ... in spotting the surging MA member utilization rates. Still, unlike The Cigna Group CI, which sold its whole Medicare business, Humana decided to continue ...

CompanyOverview\|NYSE:HUM] Health insurance giant Humana Inc. (NYSE: HUM) stock initially rose in reaction to its fourth ...